Umbilical cord clamping in the early phases of the COVID-19 era - a systematic review and meta-analysis of reported practice and recommendations in guidelines.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 22 06 2023
revised: 10 10 2023
accepted: 10 10 2023
medline: 4 12 2023
pubmed: 16 10 2023
entrez: 15 10 2023
Statut: ppublish

Résumé

At the beginning of the COVID-19 pandemic, delayed umbilical cord clamping (CC) at birth may have been commonly discouraged despite a lack of convincing evidence of mother-to-neonate SARS-CoV-2 transmission. We aimed to systematically review guidelines, and reports of practice and to analyze associations between timing of CC and mother-to-neonate SARS-CoV-2 transmission during the early phases of the pandemic. Major databases were searched from December 1, 2019, to July 20, 2021. studies and guidelines describing CC practice in women with SARS-CoV-2 infection during pregnancy until 2 postnatal days, giving birth to live-born neonates. no extractable data. Two reviewers independently screened studies for eligibility and assessed study quality. Pooled prevalence rates were calculated. Forty-eight studies (1476 neonates) and 40 guidelines were included. Delayed CC was recommended in 70.0% of the guidelines. Nevertheless, delayed CC was reported less often than early CC: 262/1476 (17.8%) vs 511/1476 (34.6%). Neonatal SARS-CoV-2 positivity rates were similar following delayed (1.2%) and early CC (1.3%). Most SARS-CoV-2 transmissions (93.3%) occurred in utero. Delayed CC did not seem to increase mother-to-neonate SARS-CoV-2 transmission. Due to its benefits, it should be encouraged even in births where the mother has a SARS-CoV-2 infection. Prospero CRD42020199500.

Identifiants

pubmed: 37839504
pii: S1201-9712(23)00747-6
doi: 10.1016/j.ijid.2023.10.010
pii:
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

63-70

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no competing interests to declare.

Auteurs

Johan Henrik Martin Berg (JHM)

Department of Clinical Sciences Lund, Pediatrics, Lund University, Lund, Sweden; Department of Neonatology, Skåne University Hospital, Lund, Sweden. Electronic address: johan.berg@med.lu.se.

Li Thies-Lagergren (L)

Department of Health Sciences, Midwifery Research - Reproductive, Perinatal, and Sexual Health, Lund University, Lund, Sweden.

Jenny Svedenkrans (J)

Department of Clinical Sciences Lund, Pediatrics, Lund University, Lund, Sweden; Department of Neonatology, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden.

Jeremiah Samkutty (J)

Academic Department of Paediatrics, Brighton and Sussex Medical School, University of Sussex, Brighton, UK.

Sara Marie Larsson (SM)

Department of Clinical Sciences Lund, Pediatrics, Lund University, Lund, Sweden; Department of Clinical Chemistry, Hospital of Halland, Varberg/Halmstad, Sweden.

Judith S Mercer (JS)

Neonatal Research Institute, Sharp Mary Birch Hospital for Women and Newborns, San Diego, USA.

Heike Rabe (H)

Academic Department of Paediatrics, Brighton and Sussex Medical School, University of Sussex, Brighton, UK.

Ola Andersson (O)

Department of Clinical Sciences Lund, Pediatrics, Lund University, Lund, Sweden; Department of Neonatology, Skåne University Hospital, Lund, Sweden.

Mehreen Zaigham (M)

Department of Clinical Sciences Lund, Obstetrics and Gynecology, Lund University, Lund, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH